Search for: "Novartis Corporation " Results 141 - 160 of 312
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Mar 2012, 7:55 am
On 3 August 2004 Novartis AG lodged a notice of opposition in respect of the goods listed above. [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Novartis Pharmaceuticals Corp., No. 33-av-00001 (D.N.J., Mar. 7, 2012) (Complaint) Plumbers and Pipefitters Local 572 Health and Welfare Fund v. [read post]
6 Mar 2012, 6:17 am
Earlier this year, Novartis Pharmaceuticals Corporation agreed to a $99 million settlement of a class action overtime lawsuit brought by its sales representatives. [read post]
14 Feb 2012, 1:45 pm
We believe in holding corporations accountable for conduct that puts our families and yours at risk every single day --and all in the name of profits. [read post]
14 Feb 2012, 1:45 pm
We believe in holding corporations accountable for conduct that puts our families and yours at risk every single day --and all in the name of profits. [read post]
24 Jan 2012, 6:34 pm by FDABlog HPM
District Court for the Northern District of Illinois (Eastern Division), the court denied Plaintiffs’ Seattle Children’s Hospital, Novartis Vaccines and Diagnostics, Inc., and Novartis Pharmaceuticals Corporation (collectively “Novartis”) Motion to Dismiss the lawsuit that they brought against Akorn, Inc. [read post]
9 Jan 2012, 4:00 am by Steve McConnell
Novartis Pharmaceuticals Corporation, Case No. 2:08-CV-02088 (W.D. [read post]
29 Dec 2011, 6:53 am by Bexis
Happy Christmas/Hanukkah/solstice and Merry New Year to all our readers. [read post]
16 Dec 2011, 9:15 pm by Patent Docs
Conference highlights include: • Benefit from industry perspectives throughout the day with IBC faculty of experienced corporate counsel; • Hear the tips and traps of current tactics for maximising patent life cycles and data exclusivity; • Gain an excellent understanding of the latest SPC position including a consideration of the judgments of key decisions including Novartis v Actavis, Medeva and Georgetown University; • Analyse the practical implications on… [read post]
15 Dec 2011, 11:57 pm by Shamnad Basheer
Justice Dalveer Bhandari recused himself from a controversial patent dispute involving Novartis' famed anti cancer drug, Glivec; a dispute that has dogged Indian courts for several years now. [read post]
5 Dec 2011, 1:20 pm
A strong answer to every IT infrastructure manager's prayers, cloud computing can provide both a scalable on-demand combination of hardware, software and services, as well as helping fulfill corporate/social mandates for becoming greener. [read post]
1 Dec 2011, 8:50 am by Randy Barnhart
The jury found that the big pharma corporation had intentionally concealed information about the unsafe use of the drug by patients. [read post]
1 Dec 2011, 8:50 am by Randy Barnhart
The jury found that the big pharma corporation had intentionally concealed information about the unsafe use of the drug by patients. [read post]
25 Nov 2011, 5:00 am by Bexis
Novartis Pharmaceuticals Corp., 2011 WL 5835414, slip op. [read post]
19 Nov 2011, 5:55 am
These findings send a clear message to all other large corporations in America that gender discrimination will not be tolerated in the workplace. [read post]
4 Nov 2011, 4:09 am by John Hopkins
Novartis Pharmaceutical paid $422.5 million to settle claims it promoted its epilepsy drug, Trileptal, for off label uses. [read post]
3 Oct 2011, 5:20 am
In addition, Mr Alexander talked the packed auditorium through some interesting procedural decisions, such as Virgin Atlantic v Delta Air on summary judgment, Cephalon v Orchid on interim injunctions or MedImmune v Novartis on expert evidence. [read post]
8 Sep 2011, 11:04 am by Tom Lamb
.; RECLAST (zoledronic acid) injection, Novartis Pharmaceuticals Corporation; and, the generic equivalents for these products, if any. [read post]